Companies330 Funding$40.1B Rounds110 ▲5 mo Investors77 Eng roles3943 ● 36 events pending
VIX The Intelligent Venture Terminal beta

RevMed

stale — 40 unprocessed events

RevMed

☆ Watch

A company developing a new drug for pancreatic cancer. observed

stale · evidence 6d ago 5 sources no confidence data
—/100
Developer momentum
Why this score? ↓
Funding
no round
Adoption
no signal
downloads / week
Developer
not scored
momentum / 100
Hiring
no board
eng openings

Traction

No traction data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.

Current round

No fundraising data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.

Opportunity & risk

No standout signal or flag yet.

4 independent sources 0 promoted signals inspect the evidence →

Evaluation

How it's evaluated Four independent layers ▾

No single number decides. Layers can disagree — that's the point. New to this? →

Platform score derived
—
Founder self-assessment claimed
8/100
Investor ratings opinion
—
Expert ratings opinion
—
Rate this company Investor or expert role required ▾
—/5 · 0 investors

Sign in as an investor or expert to rate this company.
Technology No signals collected yet ▾
No technology data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Team & hiring No signals collected yet ▾
No team & hiring data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Market & funding stage No signals collected yet ▾
No market & funding stage data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.

Evidence & scoring

Why this score? Score breakdown ▾
No score breakdown data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.

Community chatter Hacker News · Tier 3 · unverified manip. risk low · 0.2

Gray-market attention, not quality. 50+ HN mentions (peak 886 points). Claim-shaped headlines are rumors until corroborated — a Tier-3 factual claim carries no evidentiary weight on its own. Risk drivers: heavy gray-market attention. ▲ 886 Builder's Remedy goes into effect in many California cities tomorrow 2023-01-31 ↗

Raw observations 13 records ▾
AttributeValueKindSourceObservedStateConf.
common_name RevMed observed artifact ↗ 2026-07-18 normalized 0.60
community.hn.max_points 886 observed artifact ↗ 2026-07-18 normalized 0.20
community.hn.mentions 50 observed artifact ↗ 2026-07-18 normalized 0.20
community.hn.rumors [] observed artifact ↗ 2026-07-18 normalized 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=34597507", "title": "Builder's Remedy goes into effect in many California cities tomorrow", "points": 886, "created_at": "2023-01-31"} observed artifact ↗ 2026-07-18 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=34597507", "title": "Builder's Remedy goes into effect in many California cities tomorrow", "points": 886, "created_at": "2023-01-31"} observed artifact ↗ 2026-08-16 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=34597507", "title": "Builder's Remedy goes into effect in many California cities tomorrow", "points": 886, "created_at": "2023-01-31"} observed artifact ↗ 2023-01-31 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=34597507", "title": "Builder's Remedy goes into effect in many California cities tomorrow", "points": 886, "created_at": "2023-01-31"} observed artifact ↗ 2023-01-31 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=34597507", "title": "Builder's Remedy goes into effect in many California cities tomorrow", "points": 886, "created_at": "2023-01-31"} observed artifact ↗ 2023-01-31 normalized 0.20
description A company developing a new drug for pancreatic cancer. observed artifact ↗ 2026-07-18 normalized 0.60
index.ai_tie NOT_AI observed classify 2026-07-25 derived 0.60
sector biotech derived calc 2026-08-08 normalized 0.70
source.document.reference {"kind": "video", "title": "All-In — Best Ideas Pitch Competition — revmed", "source_id": "01KXRPBDZ2FE2BHN1CAREA46SJ-m-5c4590b75139d7cf", "extract_ref": "artifact:sha256:d620f51be2974e329f6969a697d1c observed artifact ↗ 2026-07-18 normalized 0.95